Polystictus Glycopeptide Capsules (Chen) – 500?mg Low price comparison

Polystictus Glycopeptide Capsules (Chen) – 500?mg Low price comparison

$1.00

Chen-brand Polystictus Glycopeptide Capsules deliver 500?mg per capsule, with a 50-count bottle. Manufactured by Jiangsu Chenpai Pharma Group and approved under H32025824, these capsules support research into chronic hepatitis B, cirrhosis, liver injury, and post-chemo/radiotherapy recovery models.
?? For laboratory and research use only. Not for clinical or diagnostic purpose.?Please consult staff for other specifications and uses?

EMI starting from $0.00/month - View Plans
Compare

Description

Polystictus Glycopeptide is a bioactive polysaccharide–peptide complex derived from Coriolus versicolor (Yunzhi), known for its immunomodulatory, hepatoprotective, and anti-inflammatory properties 
Chen’s formulation is used in research settings to model hepatic protection from alcohol-induced damage, fatty liver, cancers, and liver fibrosis via ALT/AST reduction and lipid profile improvements . These capsules are ideal for experimental studies on liver injury, immune function, detoxification, and oncology adjuncts.


Product Specifications

ParameterDetails
Product NamePolystictus Glycopeptide Capsules (Chen)
Generic IngredientYunzhi (Coriolus versicolor) intracellular glycopeptide
FormulationHard capsule
Strength0.5?g per capsule
Quantity50 capsules per bottle
Dosage FormOral capsule
Approval NumberH32025824 (NMPA China)
ManufacturerJiangsu Chenpai Pharmaceutical Co., Ltd.
Barcode6925126409114
Storage ConditionsStore 10–30?°C, cool & dry
Intended UseResearch: immune modulation, hepatoprotection, chemo-support

Mechanism of Action

The intracellular glycopeptide PSK?1c1 from Coriolus versicolor improves liver enzyme function (ALT/AST), lowers cholesterol, triglycerides, and oxidative markers (MDA, NEFA) in alcoholic and fatty liver models  It enhances immune response and reduces chemo- or radiotherapy-related myelosuppression


Research Applications

  • Chronic hepatitis B and liver injury models

  • Cirrhosis and early fibrosis assays

  • Immunoprotection post-chemotherapy/radiotherapy

  • Alcoholic liver disease and fatty liver studies

  • Antitumor adjunct research in hepatic cancer models


Safety & Handling

  • For research use only; not for clinical or veterinary use

  • Generally well tolerated; use PPE during handling

  • Store sealed; discard degraded capsules

  • Lab disposal per safety guidelines


Core Keywords

Polystictus glycopeptide capsules, Coriolus versicolor PSK?1c1, chronic hepatitis research, liver protection glycopeptide, chemo-support immunomodulator, NMPA H32025824, Jiangsu Chen pharma Yunzhi capsules


Research Use Disclaimer

This product is strictly for laboratory and preclinical research. It is not approved for clinical, therapeutic, diagnostic, or veterinary use. Misuse may pose health or regulatory risks. Use responsibly under institutional protocols.

Additional information

Weight1.1 kg
Dimensions25 × 23 × 25 cm

Reviews

There are no reviews yet.

Be the first to review “Polystictus Glycopeptide Capsules (Chen) – 500?mg Low price comparison”

Your email address will not be published. Required fields are marked *

EMI Options

Select at least 2 products
to compare